Literature DB >> 3202120

Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.

H Asamura1, T Nakajima, K Mukai, M Noguchi, Y Shimosato.   

Abstract

For determination of the degree of malignancy among thymic epithelial tumors, the DNA content and area of nuclei in 13 cases each of noninvasive thymoma, invasive thymoma, and thymic carcinoma were investigated by cytofluorometry and morphometry. The nuclear DNA content was determined in terms of the mean nuclear DNA content, DNA histogram pattern, and the occurrence of the aneuploid stem cell line. The mean nuclear DNA content of the thymic carcinoma was significantly higher than that of both subgroups of thymoma (P less than 0.01), but there was no significant difference between noninvasive and invasive thymomas. The aneuploid stem cell line appeared in 92.3% of thymic carcinomas, one case (7.7%) of invasive thymomas, and none of noninvasive thymomas. Abnormal DNA histogram patterns were seen in 53.8% of thymic carcinomas and none of the thymomas. The mean nuclear area increased significantly in the increasing order of noninvasive thymoma, invasive thymoma, and thymic carcinoma (P less than 0.01). The cytofluorometric and morphometric results demonstrated a significant difference in degree of malignancy between thymic carcinoma and thymoma; however, there was a trend toward an increasing degree of malignancy from noninvasive to invasive thymomas, yet there was a sizeable overlap in results between the two groups. Therefore, these two methods are not satisfactory for predicting the behavior of an individual case of noninvasive or invasive thymoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202120      PMCID: PMC1880827     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Evaluation of the malignant grade of thymoma by morphometric analysis.

Authors:  H Nomori; H Horinouchi; S Kaseda; T Ishihara; C Torikata
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

2.  Cellular DNA content as a marker of neoplasia in man.

Authors:  B Barlogie; B Drewinko; J Schumann; W Göhde; G Dosik; J Latreille; D A Johnston; E J Freireich
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

3.  DNA distribution in human colon carcinomas and its relationship to clinical behavior.

Authors:  R C Wolley; K Schreiber; L G Koss; M Karas; A Sherman
Journal:  J Natl Cancer Inst       Date:  1982-07       Impact factor: 13.506

4.  Thymoma. A clinicopathologic study of 54 cases.

Authors:  G F Gray; W T Gutowski
Journal:  Am J Surg Pathol       Date:  1979-06       Impact factor: 6.394

5.  Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.

Authors:  L L Vindeløv; H H Hansen; I J Christensen; M Spang-Thomsen; F R Hirsch; M Hansen; N I Nissen
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

6.  Thymoma: a ten year review.

Authors:  A N Gerein; S P Srivastava; J Burgess
Journal:  Am J Surg       Date:  1978-07       Impact factor: 2.565

7.  Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.

Authors:  T Blöndal; A Lindgren
Journal:  Anal Quant Cytol       Date:  1982-09

8.  Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation.

Authors:  T Blöndal; A Bengtsson
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

9.  Thymic carcinoma. Five distinctive histological variants.

Authors:  D C Snover; G D Levine; J Rosai
Journal:  Am J Surg Pathol       Date:  1982-07       Impact factor: 6.394

10.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  5 in total

Review 1.  Thymomas. Current experience and future directions in therapy.

Authors:  P J Loehrer
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

2.  Flow cytometric analysis of the DNA content of thymomas.

Authors:  K Kushibe; S Iioka; K Nezu; T Tojo; N Sawabata; S Kitamura
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Results from surgical treatment for thymoma. 43 years of experience.

Authors:  T Murakawa; J Nakajima; T Kohno; M Tanaka; J Matsumoto; E Takeuchi; S Takamoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-02

4.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

5.  High frequency of p53 protein expression in thymic carcinoma but not in thymoma.

Authors:  N Hino; K Kondo; T Miyoshi; T Uyama; Y Monden
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.